Alexandre Mourot1, Christian Herold2,3, Michael A Kienzler4, Richard H Kramer2. 1. Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS-IBPS), Paris, France. 2. Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA. 3. Biophysics Graduate Group, University of California Berkeley, Berkeley, CA, USA. 4. Department of Chemistry, University of Maine, Orono, ME, USA.
Abstract
BACKGROUND AND PURPOSE: The photo-isomerizable local anaesthetic, quaternary ammonium-azobenzene-quaternary ammonium (QAQ), provides rapid, optical control over pain signalling without involving genetic modification. In darkness or in green light, trans-QAQ blocks voltage-gated K+ and Na+ channels and silences action potentials in pain-sensing neurons. Upon photo-isomerization to cis with near UV light, QAQ blockade is rapidly relieved, restoring neuronal activity. However, the molecular mechanism of cis and trans QAQ blockade is not known. Moreover, the absorption spectrum of QAQ requires UV light for photo-control, precluding use deep inside neural tissue. EXPERIMENTAL APPROACH: Electrophysiology and molecular modelling were used to characterize the binding of cis and trans QAQ to voltage-gated K+ channels and to develop quaternary ammonium-ethylamine-azobenzene-quaternary ammonium (QENAQ), a red-shifted QAQ derivative controlled with visible light. KEY RESULTS: trans QAQ was sixfold more potent than cis QAQ, in blocking current through Shaker K+ channels. Both isomers were use-dependent, open channel blockers, binding from the cytoplasmic side, but only trans QAQ block was slightly voltage dependent. QENAQ also blocked native K+ and Na+ channels preferentially in the trans state. QENAQ was photo-isomerized to cis with blue light and spontaneously reverted to trans within seconds in darkness, enabling rapid photo-control of action potentials in sensory neurons. CONCLUSIONS AND IMPLICATIONS: Light-switchable local anaesthetics provide a means to non-invasively photo-control pain signalling with high selectivity and fast kinetics. Understanding the mode of action of QAQ and related compounds will help to design of drugs with improved photo-pharmacological properties. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
BACKGROUND AND PURPOSE: The photo-isomerizable local anaesthetic, quaternary ammonium-azobenzene-quaternary ammonium (QAQ), provides rapid, optical control over pain signalling without involving genetic modification. In darkness or in green light, trans-QAQ blocks voltage-gated K+ and Na+ channels and silences action potentials in pain-sensing neurons. Upon photo-isomerization to cis with near UV light, QAQ blockade is rapidly relieved, restoring neuronal activity. However, the molecular mechanism of cis and trans QAQ blockade is not known. Moreover, the absorption spectrum of QAQ requires UV light for photo-control, precluding use deep inside neural tissue. EXPERIMENTAL APPROACH: Electrophysiology and molecular modelling were used to characterize the binding of cis and trans QAQ to voltage-gated K+ channels and to develop quaternary ammonium-ethylamine-azobenzene-quaternary ammonium (QENAQ), a red-shifted QAQ derivative controlled with visible light. KEY RESULTS:trans QAQ was sixfold more potent than cis QAQ, in blocking current through Shaker K+ channels. Both isomers were use-dependent, open channel blockers, binding from the cytoplasmic side, but only trans QAQ block was slightly voltage dependent. QENAQ also blocked native K+ and Na+ channels preferentially in the trans state. QENAQ was photo-isomerized to cis with blue light and spontaneously reverted to trans within seconds in darkness, enabling rapid photo-control of action potentials in sensory neurons. CONCLUSIONS AND IMPLICATIONS: Light-switchable local anaesthetics provide a means to non-invasively photo-control pain signalling with high selectivity and fast kinetics. Understanding the mode of action of QAQ and related compounds will help to design of drugs with improved photo-pharmacological properties. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
Authors: Michael A Kienzler; Andreas Reiner; Eric Trautman; Stan Yoo; Dirk Trauner; Ehud Y Isacoff Journal: J Am Chem Soc Date: 2013-11-14 Impact factor: 15.419
Authors: Matthew R Banghart; Alexandre Mourot; Doris L Fortin; Jennifer Z Yao; Richard H Kramer; Dirk Trauner Journal: Angew Chem Int Ed Engl Date: 2009 Impact factor: 15.336
Authors: Wiktor Szymański; John M Beierle; Hans A V Kistemaker; Willem A Velema; Ben L Feringa Journal: Chem Rev Date: 2013-04-25 Impact factor: 60.622
Authors: Tae-il Kim; Jordan G McCall; Yei Hwan Jung; Xian Huang; Edward R Siuda; Yuhang Li; Jizhou Song; Young Min Song; Hsuan An Pao; Rak-Hwan Kim; Chaofeng Lu; Sung Dan Lee; Il-Sun Song; Gunchul Shin; Ream Al-Hasani; Stanley Kim; Meng Peun Tan; Yonggang Huang; Fiorenzo G Omenetto; John A Rogers; Michael R Bruchas Journal: Science Date: 2013-04-12 Impact factor: 47.728
Authors: Aleksandra Polosukhina; Jeffrey Litt; Ivan Tochitsky; Joseph Nemargut; Yivgeny Sychev; Ivan De Kouchkovsky; Tracy Huang; Katharine Borges; Dirk Trauner; Russell N Van Gelder; Richard H Kramer Journal: Neuron Date: 2012-07-26 Impact factor: 17.173
Authors: Stephen Ph Alexander; John A Peters; Eamonn Kelly; Neil Marrion; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2015-12 Impact factor: 8.739
Authors: Ido Carmi; Marco De Battista; Laura Maddalena; Elizabeth C Carroll; Michael A Kienzler; Shai Berlin Journal: Nat Protoc Date: 2019-02-25 Impact factor: 13.491
Authors: Alba Nin-Hill; Nicolas Pierre Friedrich Mueller; Carla Molteni; Carme Rovira; Mercedes Alfonso-Prieto Journal: Int J Mol Sci Date: 2021-11-08 Impact factor: 5.923